Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma
Assessment of short-term outcomes of ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma: single center non-randomized trial.
Hepatocellular Carcinoma
PROCEDURE: HALED
Short term mortality rate, Percentage of patients' postoperative deaths, 30 day
Short term major complications' rate, Incidence of Clavien/Dindo grade 3 or more postoperative complications, 30 days|Tumor response rate according to mRECIST criteria., Estimation of the residual percentage of viable tumor following the devascularization., 30 days
Assessment of the 30-day mortality and major complications as well as the tumor size changes of the patients undergoing ipsilateral lobe arterial devascularization of the large hepatocellular carcinoma. This is a prospective non randomized trial carried out at the Ribat University Hospital between April 2017 to March 2018.